PER 1.23% 8.2¢ percheron therapeutics limited

Will PER follow DXB on a similar journey ?, page-4

  1. 1,044 Posts.
    lightbulb Created with Sketch. 120
    The failure of other drugs could be a double edged sword for PER.

    On the plus side, it reduces competition for us.
    On the other side, it could make potential PER partners cautious because this is a tough disease to crack and littered with failed trials.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.001(1.23%)
Mkt cap ! $74.82M
Open High Low Value Volume
8.2¢ 8.4¢ 8.2¢ $26.81K 324.8K

Buyers (Bids)

No. Vol. Price($)
3 210052 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 671 1
View Market Depth
Last trade - 12.14pm 12/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.